CREDIT SUISSE AG/ - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$131,983,000
+349.9%
2,848,760
+136.7%
0.12%
+333.3%
Q1 2019$29,337,000
+503.9%
1,203,309
+252.9%
0.03%
+440.0%
Q4 2018$4,858,000
+74.0%
340,948
+85.6%
0.01%
+66.7%
Q3 2018$2,792,000
-34.1%
183,698
-27.3%
0.00%
-25.0%
Q2 2018$4,239,000
+13.8%
252,688
+10.7%
0.00%
+33.3%
Q1 2018$3,725,000
+35.8%
228,249
+6.5%
0.00%
+50.0%
Q4 2017$2,743,000
-6.6%
214,332
-10.2%
0.00%
-33.3%
Q3 2017$2,936,000
+25.0%
238,759
-14.9%
0.00%
+50.0%
Q2 2017$2,348,000
-38.6%
280,561
-34.5%
0.00%
-33.3%
Q1 2017$3,826,000
+198.2%
428,034
+193.3%
0.00%
+200.0%
Q4 2016$1,283,000
+16.3%
145,945
-10.6%
0.00%0.0%
Q3 2016$1,103,000
+30.8%
163,318
-31.0%
0.00%0.0%
Q2 2016$843,000
+26.4%
236,532
+4.6%
0.00%0.0%
Q1 2016$667,000
+20.4%
226,029
+72.3%
0.00%0.0%
Q4 2015$554,000
-8.0%
131,181
-0.6%
0.00%0.0%
Q3 2015$602,000
-75.2%
132,038
-60.8%
0.00%
-50.0%
Q2 2015$2,426,000
+68.9%
336,481
+72.6%
0.00%
+100.0%
Q1 2015$1,436,000
+13.6%
194,901
-27.0%
0.00%0.0%
Q4 2014$1,264,000
+313.1%
267,170
+211.2%
0.00%
Q3 2014$306,000
-44.0%
85,840
-28.3%
0.00%
Q2 2014$546,000
-20.4%
119,797
-17.9%
0.00%
-100.0%
Q1 2014$686,000
-46.3%
145,894
-42.8%
0.00%0.0%
Q4 2013$1,278,000
+90.5%
254,947
+136.4%
0.00%0.0%
Q3 2013$671,000
+42.8%
107,830
+4.1%
0.00%
Q2 2013$470,000
-44.6%
103,540
-40.0%
0.00%
-100.0%
Q1 2013$848,000172,6490.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2019
NameSharesValueWeighting ↓
BVF INC/IL 9,169,276$66,110,00011.67%
Redmile Group, LLC 13,623,620$98,226,0008.05%
First Light Asset Management, LLC 849,374$6,124,0002.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,529,361$68,707,0002.29%
Opus Point Partners Management, LLC 320,000$2,307,0001.83%
KOPP INVESTMENT ADVISORS LLC 383,022$2,762,0001.23%
Artal Group S.A. 3,710,000$26,749,0001.15%
EcoR1 Capital, LLC 400,000$2,884,0000.96%
Cormorant Asset Management, LP 850,000$6,129,0000.82%
SPHERA FUNDS MANAGEMENT LTD. 800,000$5,768,0000.56%
View complete list of ARRAY BIOPHARMA INC shareholders